Skip to Content

Aspirin use while Breastfeeding

Drugs containing Aspirin: Aspir 81, Ecotrin, Aggrenox, Excedrin, Butalbital Compound, Fiorinal, Bayer Aspirin, Aspirin Low Strength, Aspir-Low, Acetylsalicylic Acid, Show all 192 »Excedrin Migraine, Percodan, Migraine Relief, Aspirin Buffered, Anacin, Aspiritab, Ecotrin Adult Low Strength, Bufferin, Easprin, Fasprin, Ascriptin, Arthritis Pain, Norgesic, Bayer Back & Body, Bayer AM, Fiorinal with Codeine, Yosprala, Bayer Children's Aspirin, Aspirin Lite Coat, Soma Compound, Vanquish, Aspergum, Ascomp with Codeine, Excedrin Extra Strength, Buffered Aspirin, Goody's Extra-Strength Headache Powders, Bayer Aspirin Regimen, Endodan, Low Dose ASA, Ascriptin Enteric, Norgesic Forte, Empirin, Bayer Migraine Formula, Stanback, BC, BC Headache, Ecotrin Maximum Strength, ZORprin, Genacote, Acuprin 81, Farbital, Darvon Compound-65, St. Joseph 81 mg Aspirin Enteric Safety-Coated, Aspir-Mox, Robaxisal, Levacet, Adalat XL Plus, Fiortal, Fortabs, BC Fast Pain Relief, Alka-Seltzer Lemon-Lime, Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets, Bayer PM, Propoxyphene Compound 65, Equagesic, Alka-Seltzer Plus Sinus Formula, Cope, Midol Traditional, Anacin Max Strength, Synalgos-DC, Goody's Headache Powders, Migraine Formula, Alka-Seltzer Extra Strength, Pravigard Pac, Backaid Inflammatory Pain Formula, Percodan-Demi, Carisoprodol Compound, Lortab ASA, Halfprin, Aspirtab, Aspir-Mox IB, Empirin with Codeine, YSP Aspirin, Litecoat Aspirin, Entercote, Buffasal, Orphengesic Forte, Roxiprin, Momentum, Orphengesic, Talwin Compound, Bayer Headache Relief, Ache and Pain Relief to Go, P-A-C, Back & Body Extra Strength, Blowfish for Hangovers, Alka-Seltzer PM, Ursinus, Panasal 5/500, Alor 5/500, Azdone, Alka-Seltzer Plus Day & Night Cold Formula (Day Cold), Alka-Seltzer Plus Night Cold Formula Effervescent Tablets, Alka-Seltzer Plus Cold Formula Orange Zest Effervescent Tablets, Medique Medi-Seltzer, Alka-Seltzer Plus Cold & Cough Formula Effervescent Tablets, Alka-Seltzer Plus Flu Formula (old formulation), Alka-Seltzer Plus Cold Formula Cherry Burst Effervescent Tablets, Alka-Seltzer Original, Vida Mia Pain Relief, Picot Plus, Bromo Seltzer, Zee-Seltzer Antacid and Pain Reliever, Soma Compound with Codeine, Effervescent Pain Relief, Alka-Seltzer Plus Day & Night Cold Formula (Night Cold), Darvon Compound 32, PC-CAP, Micrainin, B C Powder, B C Powder Arthritis Strength, Damason-P, Bayer Women's Low Dose Plus Calcium, Stanback Fast Pain Relief, Emagrin, Winco Foods Effervescent Antacid and Pain Relief, Miniprin, Magnaprin, Arthritis Pain Formula, Ascriptin Maximum Strength, Rhinocaps, Excedrin PM Headache, Exaprin, Painaid, Arthritis Foundation Pain Reliever, Bayer Aspirin with Heart Advantage, St. Joseph 81 mg Chewable Aspirin, Bayer Aspirin Extra Strength Plus, Sloprin, Medi-Seltzer, Aspi-Cor, Bufferin Low Dose, Saleto, Extra Pain Relief, ConRx Pain Reliever, Uricalm Intensive, Pamprin Max Menstrual Pain Relief, Arthriten, Excedrin Back & Body, Excedrin Menstrual Complete, Genace, Supac, CVS Extra Strength Headache Relief, Medique Pain-Off, PainAid Extra-Strength Formula, Arthriten Inflammatory Pain Formula, Goody's Extra Strength, Anacin Advanced Headache Formula, Buffex, Durlaza, Fiormor, Idenal, Laniroif, Axotal, Bayer Advanced Aspirin, Migralex, Heartline, Fiortal with Codeine, Fiorinal with Codeine III, Genasan, Adult Strength, Aspircaf, P-A-C Analgesic, BC Arthritis, Bayer Extra Strength Back & Body, Goody's Body Pain, Zero-Order Release, Tri-Buffered Aspirin, Entaprin, Minitabs, Genprin, Extra Strength Bayer, Gennin-FC, Bufferin Arthritis Strength, Bufferin Extra Strength, Ecpirin, Bayer Women's Aspirin With Calcium, Norwich Aspirin, Stanback Analgesic, Therapy Bayer, St. Joseph Aspirin, Alka-Seltzer Wake-Up Call!

Aspirin Levels and Effects while Breastfeeding

Summary of Use during Lactation

After aspirin ingestion, salicylic acid is excreted into breastmilk, with higher doses resulting in disproportionately higher milk levels. Long-term, high-dose maternal aspirin ingestion probably caused metabolic acidosis in one breastfed infant. Reye's syndrome is associated with aspirin administration to infants with viral infections, but the risk of Reye's syndrome from salicylate in breastmilk is unknown. An alternate drug is preferred over continuous high-dose, aspirin therapy. After daily low-dose aspiring (75 to 325 mg daily), no aspirin is excreted into breastmilk and salicylate levels are low. Daily low-dose aspirin therapy may be considered as an antiplatelet drug for use in breastfeeding women.[1][2][3].

Drug Levels

Aspirin is rapidly metabolized to salicylate after ingestion, so most studies have measured salicylate levels in breastmilk after aspirin administration to the mother; however, some studies have not measured salicylate metabolites in breastmilk that may be hydrolyzed in the infant's gut and absorbed as salicylate.[4]

Maternal Levels. A woman taking aspirin 4 grams daily for rheumatoid arthritis was nursing her 5 kg infant (age not reported). Salicylate was not detectable (< 50 mg/L) in breastmilk with the relative insensitive assay used.[5]

Six nursing mothers who were 2 to 8 months postpartum (average 5 months) were given aspirin doses of 500, 1000 and 1500 mg of aspirin orally on 3 separate occasions. Peak breastmilk salicylate levels were 5.8 mg/L, 15.8 mg/L, and 38.8 mg/L, respectively. The time of the peak levels occurred between 2 and 6 hours after ingestion, with little variation in levels over time. The disproportionate increase in milk levels as the dose increased was attributed to nonlinear metabolism and protein binding.[6]

Milk and blood levels of the salicylate metabolites of aspirin were determined in 8 lactating women following oral administration of 1 g of aspirin. Peak salicylic acid milk levels averaging 2.4 mg/L occurred 3 hours after the dose. Milk contents of salicyluric acid were greater than those of salicylic acid; a mean peak level of 10.2 mg/L was reached after 9 hours, and averaged 4.4 mg/L 24 hours after the dose. Total salicylate and metabolite levels were 5.1 mg/L at 3 hours, 9.9 mg/L at 6 hours, 11.2 mg/L at 9 hours and 10.2 mg/L at 12 hours after the dose. Acid labile conjugates were less than 0.2 mg/L.[7] Using an average salicylate plus salicylurate level over the first 12 hours, a fully breastfed infant would receive an average of 9.4% of the maternal weight-adjusted dosage.

Two women given aspirin 454 mg orally had peak salicylate milk levels of about 1 mg/L 1 hour after the dose. The authors estimated that about 0.1% of the mothers' total dose would appear in breastmilk in 48 hours.[8] However, salicylate metabolites were not measured in milk.

A woman who was breastfeeding a 4-month-old was taking long-term aspirin therapy in dosages ranging from 2 to 5.9 g daily. During this therapy, milk was obtained 4 hours after a 650 mg dose and just before taking a dose of 975 mg. The trough milk salicylate level was 2 mg/L and a peak level of 10 mg/L occurred 3 hours after the dose. Salicylate levels ranged from 4 to 7 mg/L over the 5 hours after the peak.[9] Using the peak level from this study, a fully breastfed infant would receive about 10% of the maternal weight-adjusted dosage of salicylate. The assay method used should have measured both salicylate and metabolites in milk.

Seven nursing mothers between 1 and 8 months postpartum were taking enteric-coated aspirin daily; 6 took 81 mg and 1 took 325 mg. Aliquots of a complete collection of milk from both breasts were analyzed for aspirin and salicylic acid 6 times over the following 24-hour period. Aspirin was undetectable (<0.61 mcg/L) in all samples. In mothers taking 81 mg of aspirin daily, the peak salicylate concentration in milk was 115 mcg/L at 2 to 4 hours after the dose and the average milk concentration was 24 mcg/L. In the woman taking 325 mg of aspirin, the peak milk salicylate concentration was 745 mcg/L at 1 hour after the dose and the average salicylate concentration was 107.4 mcg/L. The authors calculated a weight-adjusted infant salicylate dosage of 0.4%.[3]

Infant Levels. A 9-week-old infant who was born at 36 weeks gestation was receiving about 50% breastmilk and 50% formula. The infant's mother was taking 2.4 g of aspirin daily and the infant's serum contained 65 mg/L of salicylate.[10]

Effects in Breastfed Infants

A 16-day-old breastfed infant developed metabolic acidosis with a salicylate serum level of 240 mg/L and salicylate metabolites in the urine. The mother was taking 3.9 g/day of aspirin for arthritis, and salicylate in breastmilk probably caused the infant's illness, but the possibility of direct administration to the infant could not be ruled out.[11]

Thrombocytopenia, fever, anorexia and petechiae occurred in a 5-month-old breastfed infant 5 days after her mother started taking aspirin for fever. One week after recovery, the infant was given a single dose of aspirin 125 mg and the platelet count dropped once again. The original symptoms were probably caused by aspirin or salicylate in breastmilk.[12]

Hemolysis after aspirin and phenacetin taken by the mother of a 23-day-old, G-6-PD-deficient infant was possibly due to aspirin in breastmilk.[13]

In a telephone follow-up study, mothers reported no side effects among 15 infants exposed to aspirin (dosages and infant ages were unspecified) in breastmilk.[14]

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Acetaminophen, Ibuprofen

References

1. Bell AD, Roussin A, Cartier R et al. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines executive summary. Can J Cardiol. 2011;27:208-21. PMID: 21459270

2. Bates SM, Greer IA, Middeldorp S et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141 (2 Suppl):e691S-736S. PMID: 22315276

3. Datta P, Rewers-Felkins K, Kallem RR et al. Transfer of low dose aspirin into human milk. J Hum Lact. 2017;33:296-9. PMID: 28418802

4. Levy G. Salicylate pharmacokinetics in the human neonate. In: Morselli PL, Garattini S, Sereni F, eds. Basic and therapeutic aspects of perinatal pharmacology. New York: Raven Press, 1975:319-30.

5. Erickson SH, Oppenheim GL. Aspirin in breast milk. J Fam Pract. 1979;8:189-90. PMID: 759544

6. Jamali F, Keshavarz E. Salicylate excretion in breast milk. Int J Pharm. 1981;8:285-90.

7. Putter J, Satravaha P, Stockhausen H. Quantitative analysis of the main metabolites of acetylsalicylic acid. Comparative analysis in the blood and milk of lactating women. Z Geburtshilfe Perinatol. 1974;178:135-8. PMID: 4422623

8. Findlay JW, DeAngelis RL, Kearney MF et al. Analgesic drugs in breast milk and plasma. Clin Pharmacol Ther. 1981;29:625-33. PMID: 7214793

9. Bailey DN, Welbert RT, Naylor A. A study of salicylate and caffeine excretion in the breast milk of two nursing mothers. J Anal Toxicol. 1982;6:64-8. PMID: 7098450

10. Unsworth J, d'Assis-Fonseca A, Beswick DT. Serum salicylate levels in a breast fed infant. Ann Rheum Dis. 1987;46:638-9. PMID: 3662653

11. Clark JH, Wilson WG. A 16-day-old breast-fed infant with metabolic acidosis caused by salicylate. Clin Pediatr. 1981;20:53-4. PMID: 7214793

12. Terragna A, Spirito L. [Thrombocytopenic purpura in an infant after administration of acetylsalicylic acid to the wet-nurse]. Minerva Pediatr. 1967;19:613-6. PMID: 6069440

13. Harley JD, Robin H. "Late" neonatal jaundice in infants with glucose-6-phosphate dehydrogenase-deficient erythrocytes. Aust Ann Med. 1962;11:148-55. PMID: 13960788

14. Ito S, Blajchman A, Stephenson M, Eliopoulos C et al. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 1993;168:1393-9. PMID: 8498418

Aspirin Identification

Substance Name

Aspirin

CAS Registry Number

50-78-2

Drug Class

Analgesic Agents, Nonsteroidal Antiinflammatory Agents, Platelet Aggregation Inhibitors

Administrative Information

LactMed Record Number

332

Last Revision Date

20170502

Disclaimer

Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.

Hide